M3 Inc
OTC:MTHRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M3 Inc
OTC:MTHRY
|
JP |
|
Aptose Biosciences Inc
OTC:APTOF
|
CA |
|
W
|
Wingstop Inc
F:EWG
|
US |
|
M
|
Man Group PLC
F:M3N
|
UK |
|
M
|
Maxar Technologies Inc
F:2JD
|
US |
|
Victoria Care Indonesia Tbk PT
IDX:VICI
|
ID |
Wall St Price Targets
MTHRY Price Targets Summary
M3 Inc
According to Wall Street analysts, the average 1-year price target for MTHRY is 6.7714 USD with a low forecast of 4.8764 USD and a high forecast of 10.4558 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MTHRY's stock price target?
Price Target
6.7714
USD
According to Wall Street analysts, the average 1-year price target for MTHRY is 6.7714 USD with a low forecast of 4.8764 USD and a high forecast of 10.4558 USD.
What is the Revenue forecast for M3 Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for M3 Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 2 years is 13%.
What is the Operating Income forecast for M3 Inc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 2 years is 4%.
What is the Pre-Tax Income forecast for M3 Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 2 years is 13%.
What is the Net Income forecast for M3 Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 2 years is 13%.
